Biomarkers for Immuno-Oncology

Disease immunotherapy is the utilization of the safe framework to treat tumor. Immunotherapies can be ordered as dynamic, uninvolved or half and half. These methodologies abuse the way that growth cells frequently have atoms on their surface that can be distinguished by the resistant framework, known as tumor-related antigens, they are regularly proteins or different macromolecules (e.g. sugars).

Dynamic immunotherapy guides the resistant framework to assault tumor cells by focusing on TAAs. Latent immunotherapies upgrade existing against tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes and cytokines.

  • Personalized Immunotherapy
  • Companion Diagnostics For Immunotherapy
  • Biomarkers to guide Immunotherapy
  • Clinical Trials for Cancer Immunotherapy

Related Conference of Biomarkers for Immuno-Oncology

Biomarkers for Immuno-Oncology Conference Speakers